## Abstract It has been previously described by different groups that poly(ADP‐ribose) polymerase‐1 (PARP‐1) and the product of the tumor suppressor gene p53 form tight complexes. We investigated which domains of human PARP‐1 and of human wild‐type p53 were involved in this protein–protein interact
Phosphorylation regulates the interaction and complex formation between wt p53 protein and PARP-1
✍ Scribed by Józefa Węsierska-Gądek; Jacek Wojciechowski; Gerald Schmid
- Book ID
- 102875711
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 828 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We recently characterized the interaction between poly(ADP‐ribose) polymerase‐1 (PARP‐1) and the product of the tumor suppressor gene p53. We investigated which domains of human PARP‐1 and of human wild‐type (wt) p53 were involved in this protein–protein interaction. We generated baculoviral constructs encoding full length or distinct functional domains of both proteins. Full length PARP‐1 was simultaneously coexpressed in insect cells with full length wt p53 protein or its distinct truncated fragments and vice versa. Reciprocal immunoprecipitation of Sf9 cell lysates revealed that the central and carboxy‐terminal fragments of p53 were sufficient to confer binding to PARP‐1, whereas the amino‐terminal part harboring the transactivation functional domain was dispensable. On the other hand, the amino‐terminal and central fragments of PARP‐1 were necessary for complex formation with p53 protein. As the most important features of p53 protein are regulated by phosphorylation, we addressed the question of whether its phosphorylation is essential for binding between the two proteins. Baculovirally expressed wt p53 was post‐translationally modified. At least six distinct p53 isomeres were resolved by immunoblotting following two‐dimensional separation of baculovirally expressed wt p53 protein. Using specific phospho‐serine antibodies, we identified phosphorylation of baculovirally expressed p53 protein at five distinct sites. To define the role of p53 phosphorylation, pull‐down assays using untreated and dephosphorylated p53 protein were performed. Dephosphorylated p53 failed to bind PARP‐1 indicating that complex formation between both proteins is regulated by phosphorylation of p53. The marked phosphorylation of p53 at Ser392 observed in unstressed cells suggests that the phosphorylated carboxy‐terminal part of p53 undergoes complex formation with PARP‐1 resulting in masking of the NES and thereby preventing its export. The functional significance of the interaction between both proteins was investigated at two different conditions: inactivation of PARP‐1 and overexpression of PARP‐1. Our results unequivocally show that the presence of PARP‐1 regulates the basal expression of wt p53 in unstressed cells. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract We have previously reported that human matrix metalloproteinase‐1 (MMP1) is a __p53__ target gene subject to down‐regulation (Sun et al. [1999]: J Biol Chem 274:11535–11540]. In the present study, we demonstrate that the down‐regulation of the human −83MMP1 promoter fragment by p53 was
## Interleukin-6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1 Like many other cytokines and growth factors, interleukin-6 (IL-6) activates ~21'"'. However, the precise biochemical mechanisms ind